A detailed history of Applied Finance Capital Management, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Applied Finance Capital Management, LLC holds 8,691 shares of RPRX stock, worth $229,703. This represents 0.03% of its overall portfolio holdings.

Number of Shares
8,691
Previous 12,892 32.59%
Holding current value
$229,703
Previous $340 Million 101.78%
% of portfolio
0.03%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$25.63 - $29.27 $57,539 - $65,711
2,245 Added 25.83%
10,936 $309 Million
Q3 2024

Nov 01, 2024

SELL
$25.63 - $29.27 $107,671 - $122,963
-4,201 Reduced 32.59%
8,691 $686 Million
Q2 2024

Jul 31, 2024

BUY
$26.26 - $29.9 $338,543 - $385,470
12,892 New
12,892 $340 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Applied Finance Capital Management, LLC Portfolio

Follow Applied Finance Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Applied Finance Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Applied Finance Capital Management, LLC with notifications on news.